Zobrazeno 1 - 10
of 232
pro vyhledávání: '"R. Siber"'
Autor:
M. Höge, M. Kauzlaric, R. Siber, U. Schönenberger, P. Horton, J. Schwanbeck, M. G. Floriancic, D. Viviroli, S. Wilhelm, A. E. Sikorska-Senoner, N. Addor, M. Brunner, S. Pool, M. Zappa, F. Fenicia
Publikováno v:
Earth System Science Data, Vol 15, Pp 5755-5784 (2023)
We present CAMELS-CH (Catchment Attributes and MEteorology for Large-sample Studies – Switzerland), a large-sample hydro-meteorological data set for hydrologic Switzerland in central Europe. This domain covers 331 basins within Switzerland and neig
Externí odkaz:
https://doaj.org/article/3f2bb4f954b64eee88dab45a87aca41d
Presents the latest findings on the effects of pneumococcal conjugate vaccine.
Autor:
Marc Lipsitch, George R. Siber
Publikováno v:
mBio, Vol 7, Iss 3 (2016)
ABSTRACT There is a growing appreciation for the role of vaccines in confronting the problem of antimicrobial resistance (AMR). Vaccines can reduce the prevalence of resistance by reducing the need for antimicrobial use and can reduce its impact by r
Externí odkaz:
https://doaj.org/article/596aee8b5d8b464dbf618ec8bb5c1c6a
Autor:
David Goldblatt, Joshua Liang, Ralf Clemens, Donna M. Ambrosino, Marina Johnson, Branda Hu, Htay Htay Han, George R. Siber
A significant correlation has been shown between the binding antibody responses against original SARS-CoV-2-S-protein all performed in one laboratory and vaccine efficacy of four approved COVID-19 vaccines. We therefore assessed the immune response a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07487772b47d5ef157f3253d47c1846e
https://doi.org/10.21203/rs.3.rs-902086/v1
https://doi.org/10.21203/rs.3.rs-902086/v1
Autor:
Marina Johnson, Christopher Bengt, Peter Dull, Jeremy S. Brown, Adam Hunt, Heather J. Zar, Stanley A. Plotkin, David Goldblatt, Andrew Fiore-Gartland, Donna M. Ambrosino, Dace Zavadska, Xiaoying Shen Shen, George R. Siber, Lesley Workman, David C. Montefiori
Correlates of protection for COVID-19 vaccines are urgently needed to license and deploy additional vaccines. We measured immune responses to four COVID-19 vaccines of proven efficacy using a single serological platform calibrated to the internationa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a437e70bfc4099f26478aabe23a59084
https://doi.org/10.21203/rs.3.rs-832531/v1
https://doi.org/10.21203/rs.3.rs-832531/v1
Autor:
David Goldblatt, George R. Siber, Peter Dull, Donna M. Ambrosino, Kristen A. Earle, Peter B. Gilbert, Andrew Fiore-Gartland, Stanley A. Plotkin
Publikováno v:
Vaccine
Though eleven novel COVID-19 vaccines have demonstrated efficacy, additional affordable, scalable, and deliverable vaccines are needed to meet unprecedented global demand. With placebo-controlled efficacy trials becoming infeasible due to the roll ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eade35994e12ec891e1c3e5ff4ff4afc
https://doi.org/10.1101/2021.03.17.20200246
https://doi.org/10.1101/2021.03.17.20200246
Autor:
Beth Cywin, Vicki Santos, Rick Malley, Laura L. Kovanda, Gurunadh Chichili, George R. Siber, Shite Sebastian, Ronald A. Smulders, Frank J. Malinoski
Publikováno v:
Open Forum Infectious Diseases
Background Invasive pneumococcal disease (IPD) remains prevalent despite the use of conjugate vaccines over the past 20 years. Serotype replacement, limited efficacy for certain vaccine serotypes, and the incomplete coverage of disease in the elderly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efdadf551bf0300990137b6517ce5c8b
http://europepmc.org/articles/PMC7776618
http://europepmc.org/articles/PMC7776618
Autor:
George R. Siber, Marc Lipsitch
Publikováno v:
mBio, Vol 7, Iss 3 (2016)
mBio, Vol 7, Iss 3, p e00428-16 (2016)
mBio
mBio, Vol 7, Iss 3, p e00428-16 (2016)
mBio
There is a growing appreciation for the role of vaccines in confronting the problem of antimicrobial resistance (AMR). Vaccines can reduce the prevalence of resistance by reducing the need for antimicrobial use and can reduce its impact by reducing t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c3179a2f80369e41bb4a6055866a276
https://journals.asm.org/doi/10.1128/mBio.00428-16
https://journals.asm.org/doi/10.1128/mBio.00428-16
Autor:
N. Ahlers, Beate Schmoele-Thoma, Olaf Burkhardt, A de Roux, Sherryl Baker, Tobias Welte, Stephen Lockhart, Jill G. Hackell, Philip Fernsten, William C. Gruber, George R. Siber, Hartmut Lode, Ahmad Razmpour
Publikováno v:
Vaccine. 29:4940-4946
Healthy adults aged ≥70 years (N = 443) with no history of pneumococcal vaccination received 7- or 9-valent pneumococcal conjugate vaccine (PCV7 or PCV9) at 1× (PCV7 only), 2× (PCV7 + PCV9), or 4× (2× PCV7 + 2× PCV9) dosage in a randomised, op
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a82d95e7580919896bff9c85c12deac
https://doi.org/10.1016/j.vaccine.2011.04.132
https://doi.org/10.1016/j.vaccine.2011.04.132
Autor:
Robert Weatherholtz, Lawrence H. Moulton, M. Santosham, Raymond Reid, Katherine L. O'Brien, George R. Siber
Publikováno v:
Journal of Biopharmaceutical Statistics. 16:453-462
When a sufficiently high proportion of a population is immunized with a vaccine, reduction in secondary transmission of disease can confer significant protection to unimmunized population members. We propose a straightforward method to estimate the d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2b4b8bd6ad6eb0b415a6a11508a6a35
https://doi.org/10.1080/10543400600719343
https://doi.org/10.1080/10543400600719343